• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测钌(II)配合物与扩展菲咯啉环的 DNA 结合模式的分析技术。

Analytical Techniques Used to Detect DNA Binding Modes of Ruthenium(II) Complexes with Extended Phenanthroline Ring.

机构信息

Department of Chemistry, RGUKT, Basar, Telangana State, India.

Inorganic & Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad, 500007, Telangana State, India.

出版信息

J Fluoresc. 2017 Nov;27(6):2119-2130. doi: 10.1007/s10895-017-2151-x. Epub 2017 Aug 22.

DOI:10.1007/s10895-017-2151-x
PMID:28831648
Abstract

This review describes the analytical techniques used to detect DNA-probes such as Ru(II) complexes with hetero cyclic imidazo phenanthroline (IP) ligands. Studies on drug-DNA interactions are useful biochemical techniques for visualization of DNA both in vitro and in vivo. The interactions of small molecules that binds to DNA are mainly classified into two major classes, one involving covalent binding and another non-covalent binding. Covalent binding in DNA can be irreversible and may leads to inhibition of all DNA processes which subsequently leads to cell death. Usually, covalent interactions leads to permanent changes in the structure of nucleic acids. The non-covalent interaction of molecules with DNA can be due to electrostatic interaction, intercalation and groove binding. These interactions of DNA probes can be explored by various spectroscopic techniques viz. UV-visible, emission, emission quenching spectroscopy, viscosity and thermal denaturation measurements.

摘要

本文综述了用于检测 DNA 探针的分析技术,例如与杂环咪唑并菲咯啉 (IP) 配体结合的 Ru(II) 配合物。药物-DNA 相互作用的研究是体外和体内可视化 DNA 的有用生化技术。与 DNA 结合的小分子的相互作用主要分为两类,一类涉及共价键合,另一类涉及非共价键合。DNA 中的共价键合可能是不可逆的,并且可能导致所有 DNA 过程的抑制,从而导致细胞死亡。通常,共价相互作用会导致核酸结构的永久性变化。分子与 DNA 的非共价相互作用可能是由于静电相互作用、嵌入和沟结合。可以通过各种光谱技术,例如 UV-可见、发射、发射猝灭光谱、粘度和热变性测量来探索 DNA 探针的这些相互作用。

相似文献

1
Analytical Techniques Used to Detect DNA Binding Modes of Ruthenium(II) Complexes with Extended Phenanthroline Ring.用于检测钌(II)配合物与扩展菲咯啉环的 DNA 结合模式的分析技术。
J Fluoresc. 2017 Nov;27(6):2119-2130. doi: 10.1007/s10895-017-2151-x. Epub 2017 Aug 22.
2
DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.合成的含多种嵌入型多吡啶配体的钌(II)配合物的DNA结合行为、传感器研究、抗菌性能、光裂解及体外细胞毒性
J Fluoresc. 2016 May;26(3):1101-13. doi: 10.1007/s10895-016-1800-9. Epub 2016 Apr 12.
3
DNA binding and cleavage properties of certain tetrammine ruthenium(II) complexes of modified 1,10-phenanthrolines--effect of hydrogen-bonding on DNA-binding affinity.修饰的1,10-菲咯啉的某些四胺钌(II)配合物的DNA结合和切割特性——氢键对DNA结合亲和力的影响
J Inorg Biochem. 2004 Feb;98(2):219-30. doi: 10.1016/j.jinorgbio.2003.09.003.
4
In vitro cytotoxicity, apoptosis, DNA-binding, and antioxidant activity studies of ruthenium (II) complexes.体外细胞毒性、细胞凋亡、DNA 结合和钌(II)配合物的抗氧化活性研究。
DNA Cell Biol. 2010 May;29(5):261-70. doi: 10.1089/dna.2009.0979.
5
Off-on-off pH luminescence switching and DNA binding properties of a free terpyridine-appended ruthenium complex.一种游离的联吡啶钌配合物的开-关-开pH发光切换及DNA结合特性
J Inorg Biochem. 2014 Dec;141:70-78. doi: 10.1016/j.jinorgbio.2014.08.010. Epub 2014 Sep 3.
6
Synthesis, DNA-binding and photocleavage of "light switch" complexes [Ru(bpy)2(pyip)]2+ and [Ru(phen)2(pyip)]2+.“光开关”配合物[Ru(bpy)2(pyip)]2+和[Ru(phen)2(pyip)]2+的合成、DNA 结合和光裂解。
Spectrochim Acta A Mol Biomol Spectrosc. 2010 Oct 1;77(2):522-7. doi: 10.1016/j.saa.2010.06.030. Epub 2010 Jul 1.
7
A comparative study of the interaction of two structurally analogue ruthenium(II) complexes with DNA.两种结构类似的钌(II)配合物与DNA相互作用的比较研究。
J Inorg Biochem. 2004 Dec;98(12):2011-5. doi: 10.1016/j.jinorgbio.2004.09.005.
8
A ratiometric sensor for DNA based on a dual emission Ru(dppz) light-switch complex.基于双发射 Ru(dppz) 光开关配合物的 DNA 比率型传感器。
Dalton Trans. 2017 May 9;46(18):6079-6086. doi: 10.1039/c7dt00801e.
9
DNA-binding and photocleavage studies of ruthenium(II) complexes containing asymmetric intercalative ligand.含不对称嵌入配体的钌(II)配合物的 DNA 结合和光裂解研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Feb;86:554-61. doi: 10.1016/j.saa.2011.11.014. Epub 2011 Nov 18.
10
Syntheses, characterization and DNA-binding studies of ruthenium(II) terpyridine complexes: [Ru(tpy)(PHBI)]2+ and [Ru(tpy)(PHNI)]2+.钌(II)三联吡啶配合物[Ru(tpy)(PHBI)]2 +和[Ru(tpy)(PHNI)]2 +的合成、表征及DNA结合研究
J Inorg Biochem. 2003 Jan 15;93(3-4):247-55. doi: 10.1016/s0162-0134(02)00577-9.

引用本文的文献

1
Synthesis, crystal structural description, DNA binding, molecular docking, and anticancer evaluation of the novel platinum(IV) supramolecular complex.新型铂(IV)超分子配合物的合成、晶体结构描述、DNA结合、分子对接及抗癌评估
BMC Chem. 2025 Apr 18;19(1):102. doi: 10.1186/s13065-025-01472-8.
2
Tuning anticancer properties and DNA-binding of Pt(ii) complexes alteration of nitrogen softness/basicity of tridentate ligands.调节Pt(ii)配合物的抗癌特性和DNA结合能力——三齿配体氮软度/碱度的改变
RSC Adv. 2023 Mar 21;13(14):9333-9346. doi: 10.1039/d3ra00395g. eCollection 2023 Mar 20.
3
Tuning the anticancer properties of Pt(ii) complexes structurally flexible -(2-picolyl)salicylimine ligands.

本文引用的文献

1
Correlation Between Molecular Modelling and Spectroscopic Techniques in Investigation With DNA Binding Interaction of Ruthenium(II) Complexes.分子建模与光谱技术在研究钌(II)配合物与 DNA 结合相互作用中的相关性。
J Fluoresc. 2017 Mar;27(2):587-594. doi: 10.1007/s10895-016-1986-x. Epub 2016 Dec 6.
2
Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.单核铜(II) 多吡啶配合物的抗血管生成活性用于癌症治疗。
J Med Chem. 2015 Jul 9;58(13):5226-41. doi: 10.1021/acs.jmedchem.5b00651. Epub 2015 Jun 24.
3
Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes.
通过结构灵活的-(2-吡啶甲基)水杨醛亚胺配体调节Pt(ii)配合物的抗癌特性。
RSC Adv. 2022 Sep 27;12(42):27582-27595. doi: 10.1039/d2ra04992a. eCollection 2022 Sep 22.
4
DNA-Binding and Cytotoxicity of Copper(I) Complexes Containing Functionalized Dipyridylphenazine Ligands.含功能化联吡啶吩嗪配体的铜(I)配合物的DNA结合与细胞毒性
Pharmaceutics. 2021 May 20;13(5):764. doi: 10.3390/pharmaceutics13050764.
5
DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands.偕环戊二烯基钌(II)配合物与(多)环芳烃二胺配体的 DNA 结合能力和抗癌活性。
Molecules. 2020 Dec 26;26(1):76. doi: 10.3390/molecules26010076.
钌(II)多吡啶配合物的细胞摄取、细胞毒性、凋亡、DNA结合、光裂解及分子对接研究
J Photochem Photobiol B. 2014 Mar 5;132:111-23. doi: 10.1016/j.jphotobiol.2014.02.003. Epub 2014 Feb 18.
4
Cellular uptake, cytotoxicity, apoptosis and DNA-binding investigations of Ru(II) complexes.钌(II)配合物的细胞摄取、细胞毒性、细胞凋亡及DNA结合研究。
Eur J Med Chem. 2014 Jan 24;72:160-9. doi: 10.1016/j.ejmech.2013.11.005. Epub 2013 Nov 25.
5
New 4-thiazolidinones of nicotinic acid with 2-Amino-6-methylbenzothiazole and their biological activity.新型含2-氨基-6-甲基苯并噻唑的烟酸4-噻唑烷酮及其生物活性。
Sci Pharm. 2010 Oct-Dec;78(4):753-65. doi: 10.3797/scipharm.1009-15. Epub 2010 Oct 24.
6
Synthesis, characterization, DNA binding properties, fluorescence studies and toxic activity of cobalt(III) and ruthenium(II) polypyridyl complexes.钴(III)和钌(II)多吡啶配合物的合成、表征、DNA 结合性质、荧光研究和毒性活性。
J Fluoresc. 2011 Mar;21(2):563-72. doi: 10.1007/s10895-010-0743-9. Epub 2010 Oct 8.
7
DNA-binding studies of mixed-ligand (ethylenediamine)ruthenium(II) complexes.混合配体(乙二胺)钌(II)配合物的DNA结合研究
Chem Biodivers. 2006 Nov;3(11):1219-29. doi: 10.1002/cbdv.200690123.
8
Design of targeting ligands in medicinal inorganic chemistry.药物无机化学中靶向配体的设计。
Chem Soc Rev. 2006 Jun;35(6):534-44. doi: 10.1039/b514859f. Epub 2006 Apr 20.
9
[University clinics in the competitive hospital market].[竞争激烈的医院市场中的大学诊所]
Anaesthesist. 2005 Jul;54(7):694-702. doi: 10.1007/s00101-005-0860-z.
10
Interaction of polypyridyl ruthenium (II) complex containing asymmetric ligand with DNA.含不对称配体的多吡啶钌(II)配合物与DNA的相互作用
J Inorg Biochem. 2005 Feb;99(2):530-7. doi: 10.1016/j.jinorgbio.2004.10.030.